Records containing: Renal Insufficiency
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-04-28B-type Natriuretic Peptide for Cardio-Renal Decompensation Syndrome
-
CLINICAL_TRIALS study record update · 2015-03-06Clinical Pharmacology Study of FYU-981 for Subjects With Renal Insufficiency.
-
CLINICAL_TRIALS study record update · 2015-02-10An Open-Label, Single-Dose Study to Investigate the Pharmacokinetics of MK-8616 in Subjects With Moderate and Severe Renal Insufficiency
-
CLINICAL_TRIALS study record update · 2015-02-04Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney Transplantation in Vivo
-
CLINICAL_TRIALS study record update · 2015-02-02Making Accurate Problem Lists in the EHR
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-01-15Clinical Study to Investigate the Safety and Pharmacokinetics of Udenafil Tablet in Renal Impaired Male Patients
-
CLINICAL_TRIALS study record update · 2014-12-24ClinicalTrials.gov study NCT02324400
-
CLINICAL_TRIALS study record update · 2014-12-03Predictive Value of Biomarkers on Volemia, Extra and Intra Vascular Varation and Hydroelectrolytic Disorders in Different ICU Patients
-
CLINICAL_TRIALS study record update · 2014-11-25A Multicenter, Open-Label, Single-dose, Pharmacokinetic and Safety Study of Dexpramipexole (BIIB050) in Healthy Subjects and Subjects With Renal Impairment
-
CLINICAL_TRIALS study record update · 2014-11-04A Prospective Cohort Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 3 to 5 Chronic Kidney Disease Undergoing MRI With the Injection of MultiHance
-
CLINICAL_TRIALS study record update · 2014-11-04A Prospective Cohort Study Evaluating the Incidence of Nephrogenic Systemic Fibrosis in Patients With Stages 3 to 5 Chronic Kidney Disease Undergoing MRI With the Injection of ProHance
-
CLINICAL_TRIALS study record update · 2014-10-10GEHC Has Decided Not to Provide This Detail But Will Rely on the Brief Title.
-
CLINICAL_TRIALS study record update · 2014-10-08An Open-Label Study to Estimate the Effect of Multiple Doses of Erythromycin on the Pharmacokinetics, Pharmacodynamics and Safety of a Single Dose of Rivaroxaban in Subjects With Renal Impairment and Normal Renal Function
-
CLINICAL_TRIALS study record update · 2014-09-22Prospective Non-randomized Observational (Pharmacoepidemiologic) Cohort Study (Open-label, Multicenter) to Assess the Magnitude of Potential Risk With the Administration of Magnevist® Injection in Patients With Moderate Renal Impairment for the Development of Nephrogenic Systemic Fibrosis (NSF) Based on Diagnostically Specific Clinical and Histopathologic Information.
-
CLINICAL_TRIALS study record update · 2014-09-01Pharmacokinetic Study of Fondaparinux in Inpatients With Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2014-07-18Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of 150 mg Dabigatran Etexilate p.o. in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function in a Monocentric, Open, Parallel-group Trial
-
CLINICAL_TRIALS study record update · 2014-07-17A Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive OMNISCAN (Gadodiamide Injection) for Contrast-enhanced Magnetic Resonance Imaging.
-
CLINICAL_TRIALS study record update · 2014-07-16ASP1585 Phase 3 Randomized Double Blind Placebo-controlled Study in Chronic Kidney Disease (CKD) Patients With Hyperphosphatemia Not on Dialysis
-
CLINICAL_TRIALS study record update · 2014-07-16Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Single and Multiple 5 mg Doses of Linagliptin Tablets in Patients With Different Degrees of Renal Impairment in Comparison to Subjects With Normal Renal Function in a Monocentric, Open, Parallel-group, Phase I Trial
-
CLINICAL_TRIALS study record update · 2014-07-14An Open-Label, Single Dose Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine (VIRAMUNE®)
-
CLINICAL_TRIALS study record update · 2014-06-24A Comparison of Indapamide SR 1.5 mg With Hydrochlorothiazide 25 mg, in Combination With an ACE-inhibitor, in Old Patients With Mild to Moderate Renal Insufficiency and Hypertension
-
CLINICAL_TRIALS study record update · 2014-06-24The Pharmacokinetic, Safety and Tolerability of Tiotropium (4.8 mcg, Single i.v. Dose) in Outpatients With Renal Impairment in Comparison to Healthy Subjects (Open Label, Group Comparison, Two-center Study)
-
CLINICAL_TRIALS study record update · 2014-06-17A Human Physiologic Study to Evaluate the Renal and Neurohumoral Effects of Dual NPR-A and NPR-B Activation With a Novel Chimeric Natriuretic Peptide (CD-NP)in Subjects With Stable Chronic Heart Failure and Moderate Renal Dysfunction
-
CLINICAL_TRIALS study record update · 2014-06-16A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of BI 10773 (10 mg and 25 mg Administered Once Daily) as Add on to Pre-existing Antidiabetic Therapy Over 52 Weeks in Patients With Type 2 Diabetes Mellitus and Renal Impairment and Insufficient Glycaemic Control
-
CLINICAL_TRIALS study record update · 2014-06-02An Open-Label, Single-dose, Pharmacokinetic, Pharmacodynamic, and Safety Study of PEGylated Interferon Beta-1a (BIIB017) in Healthy Subjects and Subjects With Renal Impairment